RPS Appoints Mark D. Myslinski Chief Executive Officer
Sarasota, Florida (PRWEB) January 23, 2012 Rapid Pathogen Screening, Inc. (RPS?) is pleased to announce the appointment of Mark D. Myslinski as Chief Executive Officer.
Myslinski brings nearly 30 years of successful leadership experience in life sciences and diagnostic companies ranging from Fortune 100 companies to small, venture-backed start up organizations. Before joining RPS, Myslinski has held positions as Senior Vice President and General Manager, Diagnostics of Hologic, Inc. Prior to that, Myslinski was President and CEO of RedPath Integrated Pathology, Inc. He has also successfully led Veridex LLC, a subsidiary of Johnson & Johnson?s Ortho-Clinical Diagnostics, as General Manager where the team pioneered the clinical use of circulating tumor cells.
?Mark brings a wealth of knowledge and valuable point of care diagnostic experience to RPS,? said Robert Sambursky MD, President, Chief Medical Officer, and Executive Chairman of RPS. ?His diverse background and stro...